3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Lung Neoplasms
23
Carcinoma, Non-Small-Cell Lung
16
Ovarian Neoplasms
12
Fallopian Tube Neoplasms
11
Carcinoma, Hepatocellular
10
Urinary Bladder Neoplasms
7
Pancreatic Neoplasms
7
Melanoma
7
Colorectal Neoplasms
7
Carcinoma, Renal Cell
7
Triple Negative Breast Neoplasms
6
Squamous Cell Carcinoma of Head and Neck
5
Neoplasm Metastasis
5
Mycosis Fungoides
5
Endometrial Neoplasms
5
Breast Neoplasms
5
Lymphoma, T-Cell, Cutaneous
4
Glioblastoma
4
Thyroid Neoplasms
3
Sezary Syndrome
3
Nasopharyngeal Carcinoma
3
Multiple Myeloma
3
Mouth Neoplasms
3
Lymphoma, T-Cell
3
Colonic Neoplasms
3
Cholangiocarcinoma
3
Carcinoma, Transitional Cell
3
Carcinoma
3
Brenner Tumor
3
Brain Neoplasms
3
Interventions
pembrolizumab
4
aldesleukin
3
Cisplatin
3
lenvatinib
2
Surveys and Questionnaires
2
Specimen Handling
2
Paclitaxel
2
Nivolumab
2
Magnetic Resonance Spectroscopy
2
Adoptive Transfer
2
zimberelimab
1
trastuzumab deruxtecan
1
tivozanib
1
liposomal doxorubicin
1
fludarabine phosphate
1
fludarabine
1
entinostat
1
dostarlimab
1
cemiplimab
1
bintrafusp alfa protein, human
1
belzutifan
1
atezolizumab
1
Therapeutic Touch
1
Taxes
1
Standard of Care
1
Sonazoid
1
Respiratory Function Tests
1
Radiotherapy
1
Radiation
1
Prochlorperazine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Vulvar Neoplasms
×
Immunoglobulin G
×
1 year
×
Clear all
No trials found.